Department of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid, Spain.
Surgical Pathology, Hospital Clínico Universitario San Carlos, Madrid, Spain.
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2019-000432.
Tumor-infiltrating lymphocytes (TILs), mainly CD8 cytotoxic T lymphocytes (CTL), are linked to immune-mediated control of human cancers and response to immunotherapy. Tumors have nonetheless developed specific mechanisms that selectively restrict T cell entry into the tumor microenvironment. The extracellular superoxide dismutase (SOD3) is an anti-oxidant enzyme usually downregulated in tumors. We hypothesize that upregulation of SOD3 in the tumor microenvironment might be a mechanism to boost T cell infiltration by normalizing the tumor-associated endothelium.
Here we show that SOD3 overexpression in endothelial cells increased in vitro transmigration of naïve and activated CD4 and CD8 T cells, but not of myeloid cells. Perivascular expression of SOD3 also specifically increased CD4 and CD8 effector T cell infiltration into tumors and improved the effectiveness of adoptively transferred tumor-specific CD8 T cells. SOD3-induced enhanced transmigration in vitro and tumor infiltration in vivo were not associated to upregulation of T cell chemokines such as CXCL9 or CXCL10, nor to changes in the levels of endothelial adhesion receptors such as intercellular adhesion molecule-1 (ICAM-1) or vascular cell adhesion molecule-1 (VCAM-1). Instead, SOD3 enhanced T cell infiltration via HIF-2α-dependent induction of specific WNT ligands in endothelial cells; this led to WNT signaling pathway activation in the endothelium, FOXM1 stabilization, and transcriptional induction of laminin-α4 (LAMA4), an endothelial basement membrane component permissive for T cell infiltration. In patients with stage II colorectal cancer, SOD3 was associated with increased CD8 TIL density and disease-free survival. SOD3 expression was also linked to a T cell-inflamed gene signature using the COAD cohort from The Cancer Genome Atlas program.
Our findings suggest that SOD3-induced upregulation of LAMA4 in endothelial cells boosts selective tumor infiltration by T lymphocytes, thus transforming immunologically "cold" into "hot" tumors. High SOD3 levels are associated with human colon cancer infiltration by CD8 T cells, with potential consequences for the clinical outcome of these patients. Our results also uncover a cell type-specific, distinct activity of the WNT pathway for the regulation of T cell infiltration into tumors.
肿瘤浸润淋巴细胞(TILs),主要是 CD8 细胞毒性 T 淋巴细胞(CTL),与人类癌症的免疫介导控制和免疫治疗反应有关。然而,肿瘤已经发展出了特定的机制,这些机制选择性地限制了 T 细胞进入肿瘤微环境。细胞外超氧化物歧化酶(SOD3)是一种抗氧化酶,通常在肿瘤中下调。我们假设,肿瘤微环境中 SOD3 的上调可能是通过使肿瘤相关内皮细胞正常化来促进 T 细胞浸润的一种机制。
在这里,我们表明内皮细胞中 SOD3 的过表达增加了幼稚和激活的 CD4 和 CD8 T 细胞的体外迁移,但不增加髓样细胞的迁移。血管周表达的 SOD3 也特异性地增加了 CD4 和 CD8 效应 T 细胞浸润到肿瘤中,并提高了过继转移的肿瘤特异性 CD8 T 细胞的有效性。SOD3 诱导的体外迁移增强和体内肿瘤浸润与 T 细胞趋化因子(如 CXCL9 或 CXCL10)的上调无关,也与内皮细胞黏附受体(如细胞间黏附分子-1(ICAM-1)或血管细胞黏附分子-1(VCAM-1)的水平变化无关。相反,SOD3 通过内皮细胞中 HIF-2α 依赖性诱导特定的 WNT 配体,增强 T 细胞浸润;这导致内皮细胞中 WNT 信号通路的激活、FOXM1 的稳定和层粘连蛋白-α4(LAMA4)的转录诱导,LAMA4 是允许 T 细胞浸润的内皮基底膜成分。在 II 期结直肠癌患者中,SOD3 与 CD8 TIL 密度和无病生存率增加有关。SOD3 的表达也与 COAD 队列的 TCGA 程序中的 T 细胞炎症基因特征有关。
我们的研究结果表明,SOD3 诱导的内皮细胞中 LAMA4 的上调促进了 T 淋巴细胞对肿瘤的选择性浸润,从而将免疫“冷”肿瘤转化为“热”肿瘤。高 SOD3 水平与人类结肠癌中 CD8 T 细胞的浸润有关,这可能对这些患者的临床结局产生影响。我们的研究结果还揭示了 WNT 通路对调节 T 细胞浸润到肿瘤中的一种细胞类型特异性的独特活性。